knowledge -WSS

knowledge

author：fashion 2025-09-30 00:47:20 - browse：5938

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Mega Millions pot grows to $1.25 billion after no winner

Wikipedia

WSS

Listen: PBM conflicts, RSV vaccines, & the future of flu season

No plane should take off without an EpiPen onboard

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Vertex non

Did the public have the right to know Arthur Ashe had AIDS?

leisure time

knowledge

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Community addresses injustice for Long Island mothers

Psychedelics group wrestles with new pharma identity

What the US credit downgrade means for the economy, your finances

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

RaDonda Vaught case: a double standard for nurses, physicians

Tori Bowie and the unacceptable rates of Black maternal death

Micronoma's microbiome cancer diagnostic approach under fire

Walensky prepares to leave CDC — and Congress — behind

What to expect as Trump is arraigned on his Jan 6. indictment

focus

‘Oppenheimer’ and the risks of AI in health care

5 important ways Henrietta Lacks changed medical science

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Did the public have the right to know Arthur Ashe had AIDS?

PhRMA sues HHS over Medicare drug price negotiation

Wikipedia

entertainment

Wikipedia

hotspot